On April 21, 2023, Suzhou Zelgen Biopharmaceuticals Co., Ltd. closed the transaction. The company issued 24,489,795 shares for the gross proceeds of CNY 1,455,290,000. The company?s total capital changed from 240,000,000 shares to 264,489,795.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
55.3 CNY | -0.14% | +0.36% | +4.46% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+4.46% | 2.03B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- 688266 Stock
- News Suzhou Zelgen Biopharmaceuticals Co.,Ltd.
- Suzhou Zelgen Biopharmaceuticals Co., Ltd. announced that it has received CNY 1.45529 billion in funding